SelectQuote(US:SLQT)2026-02-05 14:02Financial Data and Key Metrics Changes - SelectQuote reported a revenue growth of 12% year-over-year, totaling $537 million, driven by both Senior and Healthcare Services businesses [21] - Senior revenue grew 2% to $262 million, with adjusted EBITDA of $102 million, maintaining near record margins of 39% [22][23] - Healthcare Services revenue increased by 26% year-over-year to $231 million, with membership growing 17% to 113,000 [22][24] - Operating cash flow for fiscal 2026 is expected to be $25 million-$35 million, representing a significant increase compared to the previous year [29][31] Business Line Data and Key Metrics Changes - The Senior division achieved an EBITDA margin of 39%, marking the fourth consecutive AEP season above 30% [10][22] - Healthcare Services segment revenue growth of 26% year-over-year reflects strong demand for SelectRx services [5][24] - Life insurance revenue grew 9% to $44 million, driven by a strong quarter for final expense, while term Life business remained flat [24] Market Data and Key Metrics Changes - The Medicare Advantage market experienced significant disruptions, with approximately 7% of plans canceled by carriers, compared to a historical average below 1% [13][14] - SelectQuote's recapture rate improved to 33%, indicating strong customer retention amidst market volatility [15] Company Strategy and Development Direction - SelectQuote's strategy focuses on agent retention and proactive engagement with policyholders to navigate market disruptions [10][15] - The company aims to prioritize profitability and cash flow over growth, leveraging its diversified model to capitalize on market opportunities [20][54] - A new $415 million credit facility enhances capital flexibility, allowing the company to invest strategically while managing debt maturities [7][26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth, profitability, and cash flow potential despite recent headwinds impacting fiscal 2026 guidance [8][28] - The company remains committed to providing high-quality service to beneficiaries, which is increasingly valuable in a challenging market environment [17][54] Other Important Information - SelectQuote entered a multi-year agreement with a pharmacy benefit manager (PBM), improving visibility into drug reimbursement pricing [6][34] - The company anticipates a $40 million aggregate impact on fiscal 2026 guidance due to changes in PBM reimbursement and a national carrier's marketing budget cuts [7][28] Q&A Session Summary Question: Details on the PBM deal and its impact - Management confirmed that the new PBM arrangement provides stability and predictability, addressing the $20 million hit in fiscal 2026 as a one-time issue [34][35] Question: Risks of other carriers following the marketing budget cuts - Management indicated that the decision to cut marketing budgets was not unique to SelectQuote and expressed confidence in navigating through these challenges [36] Question: Opportunities for SelectQuote in the current market - Management highlighted the company's unique capabilities and efficiency, positioning it well to capture market share amidst financial stress in the healthcare system [42][43] Question: Negotiating position with SelectRx due to scale - Management noted that the scale of SelectRx has enhanced negotiating power, allowing for deeper partnerships and better terms with PBM [58][60] Question: Incremental volume absorption at the Kansas facility - Management stated that the Kansas facility has significant capacity for expansion without requiring meaningful new capital investment [61][63]